Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Relay Therapeutics Inc
(NQ:
RLAY
)
7.120
-0.190 (-2.60%)
Streaming Delayed Price
Updated: 2:39 PM EDT, Jun 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
701,363
Open
7.300
Bid (Size)
7.110 (7)
Ask (Size)
7.130 (7)
Prev. Close
7.310
Today's Range
6.965 - 7.500
52wk Range
5.700 - 13.32
Shares Outstanding
121,613,181
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
AI-Focused Drug Discovery Stocks Portfolio Down 4% W/e June 14th
Today 13:33 EDT
The global
Via
Talk Markets
AI-Focused Drug Discovery Stocks Portfolio Down 2% In May; Up 4% Last Week
June 10, 2024
The global
Via
Talk Markets
Performance
YTD
-39.94%
-39.94%
1 Month
+7.23%
+7.23%
3 Month
-5.07%
-5.07%
6 Month
-30.13%
-30.13%
1 Year
-41.25%
-41.25%
More News
Read More
Expert Ratings For Relay Therapeutics
June 07, 2024
Via
Benzinga
Relay Therapeutics Discloses Three New Programs at New Program & Platform Event
June 06, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Relay Therapeutics Announces Clinical Trial Collaboration with Pfizer to Evaluate Atirmociclib in Combination with RLY-2608
June 05, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Key Takeaways From Relay Therapeutics Analyst Ratings
May 10, 2024
Via
Benzinga
Relay Therapeutics: Q4 Earnings Insights
February 22, 2024
Via
Benzinga
Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week
May 27, 2024
Via
Talk Markets
Relay Therapeutics to Participate in Upcoming Investor Conferences
May 21, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Relay Therapeutics to Host New Program and Platform Event on June 6, 2024
May 13, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
5 Of 7 AI Categories Rose, Slightly,Over Past Week
May 11, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
The 7 AI Categories Declined, On Average, The First Week Of May
May 05, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May
May 05, 2024
Via
Talk Markets
RLAY Stock Earnings: Relay Therapeutics Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
Via
InvestorPlace
Relay Therapeutics Reports First Quarter 2024 Financial Results and Corporate Highlights
May 02, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Relay Therapeutics to Announce First Quarter 2024 Financial Results and Corporate Highlights on May 2, 2024
April 25, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Clinical-Stage BioTech Drug Stocks Portfolio Went Down 9% Last Week
April 23, 2024
Via
Talk Markets
Relay Therapeutics to Participate in Upcoming Investor Conferences
April 11, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
April 10, 2024
Via
Benzinga
AI Surge Ending: Only One Category Was Up This Week
April 06, 2024
Via
Talk Markets
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
3 Precision Medicine Stocks That Could Benefit From the Industry’s Rise
March 15, 2024
Via
InvestorPlace
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
March 04, 2024
Via
Talk Markets
Relay Therapeutics to Participate in Three Upcoming Investor Conferences
February 26, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
February 22, 2024
From
Relay Therapeutics, Inc.
Via
GlobeNewswire
Earnings Scheduled For February 22, 2024
February 22, 2024
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.